Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.530
-0.037 (-6.59%)
Nov 5, 2024, 3:50 PM EST - Market open

MTNB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-22.91-22.94-21-23.28-22.45-17.37
Upgrade
Depreciation & Amortization
0.960.940.90.780.770.78
Upgrade
Other Amortization
0.110.110.210.250.240
Upgrade
Loss (Gain) From Sale of Assets
0000-0.01
Upgrade
Loss (Gain) From Sale of Investments
----0.01-
Upgrade
Stock-Based Compensation
4.454.955.234.294.562.99
Upgrade
Other Operating Activities
-0.09-0.291.2--
Upgrade
Change in Accounts Payable
-0.37-0.1-0.320.59-0.330.38
Upgrade
Change in Other Net Operating Assets
-0.021.77-4.470.95-0.18-0.88
Upgrade
Operating Cash Flow
-17.87-15.28-19.16-15.22-17.37-14.09
Upgrade
Capital Expenditures
-0.02-0.22-0.89-0.26-0.01-0.41
Upgrade
Investment in Securities
3.1213.465.7717.03-40.66-5.61
Upgrade
Investing Cash Flow
3.1113.244.8816.77-40.67-6.01
Upgrade
Short-Term Debt Repaid
------0.2
Upgrade
Long-Term Debt Repaid
--0.01-0.02-0.03-0.05-0.08
Upgrade
Total Debt Repaid
-0-0.01-0.02-0.03-0.05-0.28
Upgrade
Net Debt Issued (Repaid)
-0-0.01-0.02-0.03-0.05-0.28
Upgrade
Issuance of Common Stock
9.24-0.1748.130.13
Upgrade
Financing Cash Flow
9.24-0.010.086.9748.0529.85
Upgrade
Net Cash Flow
-5.53-2.04-14.28.51-9.999.75
Upgrade
Free Cash Flow
-17.89-15.5-20.05-15.48-17.37-14.5
Upgrade
Free Cash Flow Margin
--1413.87%-628.86%-46918.18%-10972.81%-16142.24%
Upgrade
Free Cash Flow Per Share
-3.97-3.57-4.62-3.68-4.41-4.99
Upgrade
Levered Free Cash Flow
-9.13-6.85-14.39-8.25-9.76-9.92
Upgrade
Unlevered Free Cash Flow
-9.24-6.96-14.6-8.5-10-9.91
Upgrade
Change in Net Working Capital
-0.22-2.234.47-2.150.21.45
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.